Worldwide Biologics and Biosimilars market is valued at 144.7 Billion US$ in 2017 and will reach 220.3 Billion US$ by the end of 2025, growing at a CAGR of 5.4% during 2018-2025.

Press Release

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Most biologics manufacturer are concentrated in the US, Germany, UK and other developed countries. But in the biosimilars industry, the situation is different, manufacturer in developing countries play a very important role.
Through the research, we tend to believe that the growth of the biologics industry may be slow but has high profits during the period of a patent may be attractive. As to biosimilars, now is a chance for newcomers and they will greatly change the industry.

The global Biologics and Biosimilars market is valued at 144700 million US$ in 2017 and will reach 220300 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2018-2025.

Global Biologics and Biosimilars Market Professional Survey Report 2018 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2019 through 2025. Also, a five-year historic analysis is provided for these markets in this 109 pages report.

This market report provides in-depth analytics of the Biologics and Biosimilars industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Biologics and Biosimilars research report

Biologics and Biosimilars market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:

Johnson & Johnson
Novo Nordisk
Eli Lilly
Changchun High Tech
CP Guojian
Dong Bao
United Laboratories

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:

Growth Factors

By Industrial Application, the market can be split into:


Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Biologics and Biosimilars Market Professional Survey Report 2018


Trusted Business Insights
Jessica Wang
Media & Marketing Executive
[email protected]
US: +1 646 568 9797
UK: +44 330 808 0580